The Work We Do Now Affects Health Care’s Future
The World Health Organization designated 2020 internationally as the Year of the Nurse and Midwife in honor of Florence Nightingale’s 200th birthday. To celebrate the work that nurses do globally, nursing organizations around the world are creating programs that offer recognition—as well as education, training, and professional development.
Eliminating Private Insurance; Raising the Smoking Age; HPV Vaccine Recommendation
Candidates in the first Democratic presidential debate spent some time addressing issues related to healthcare access. In point-blank questions, they were asked what they might do in support of Medicare for All, especially whether they’d be in favor of eliminating private insurance companies. Many were supportive of the overarching legislation, some were wary of eliminating insurance companies outright, and others flat out opposed it.
- Read more about Eliminating Private Insurance; Raising the Smoking Age; HPV Vaccine Recommendation
- Add new comment
Here’s How You Can Confront Workplace Violence in a Healthcare Setting
RNs encounter workplace violence and abuse at a far higher rate than in any other profession in the United States. Although the topic is uncomfortable, it’s a very real aspect of health care for many professionals. Most nurses have likely experienced an abusive, dangerous, or violent encounter in the healthcare setting at some point in their careers.
- Read more about Here’s How You Can Confront Workplace Violence in a Healthcare Setting
- Add new comment
FDA Grants Accelerated Approval to Selinexor for Multiple Myeloma
On July 3, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to selinexor (XpvioTM) in combination with dexamethasone for adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.
Test Predicts Which Women Will Benefit From Chemo for Breast Cancer
A prediction test accurately identifies which women with estrogen receptor (ER)-positive, HER2-negative breast cancer will benefit from adjuvant chemotherapy, according to the results of a study published in Breast Cancer Research and Treatment.
Support and Empower At-Home Caregivers of Patients With Cancer
Finding comfort among loved ones at home can be conducive to healing in all of its dimensions for patients with cancer. For patients in home care, many aspects of treatment and day-to-day medical care are done by loved ones or family members. In the United States, nearly 4.6 million at-home caregivers are tending to patients with cancer. Although many at-home caregivers embrace the responsibility, managing successful oncology care can be a complex burden for family members—many of whom are likely unprepared for the stressors of cancer care.
No Place Like It: Home Care for Patients With Cancer
It’s more than just four walls and a roof. Home is where most people find comfort, solace, and a sense of familiarity. It’s where the heart is, and there’s no place like it. With advancements in cancer therapies, treatment care modalities, and technology, many of today’s patients are finding they can receive a large portion of their care in the home. Home care is not a new concept—rather it’s likely the oldest healthcare setting in human history—but it can be a complex and intricate care environment, especially when addressing specific needs related to cancer treatment. At its heart are expert oncology nursing professionals who safely deliver the best possible care for their patients—in the comfort of their own homes.
Healthcare Price Transparency; Cancer Survivor Caucus; Insurers Sue for ACA Backpay
Since 2016, then-candidate Trump promised he was going to bring healthcare costs under control. In a White House announcement on June 24, 2019, the president took steps to add transparency to the process by requiring insurance companies, hospitals, and physicians to identify fees and costs in public and simple ways for patients to see in advance and to understand.
- Read more about Healthcare Price Transparency; Cancer Survivor Caucus; Insurers Sue for ACA Backpay
- Add new comment
FDA Approves Daratumumab for Multiple Myeloma Ineligible for Autologous Stem Cell Transplant
On June 27, 2019, the U.S. Food and Drug Administration (FDA) approved daratumumab (Darzalex®) in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
- Read more about FDA Approves Daratumumab for Multiple Myeloma Ineligible for Autologous Stem Cell Transplant
- Add new comment